1.
Pediatr Infect Dis J
; 39(9): e276-e278, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32496409
RESUMO
We evaluated 113 pediatric patients with chronic hepatitis C from 2009 to 2019 at a Brazilian tertiary center. Seventy patients received pegylated-interferon treatment. The sustained virologic response was 61.4%, and 92.8% reported side effects. Currently, we are following 39 patients with chronic hepatitis C, 24 of whom are eligible for treatment with direct-acting antivirals according to Brazilian recommendations.